Prostate cancer research program to improve quality of life to enhance outcomes and overall health and wellness for those service members impacted by prostate cancer.
Ended Awarded Last action
- Contract number
- HT942525F0213
- Awardee
-
Leidos, Inc. UEI QLNMVC12KWY3 Part of Leidos Holdings, Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $227,813
Award facts
- Opportunity
-
- Meeting, Programmatic, and Administrative Support Services Pre-Solicitation · W81XWH22R0025 · Posted Aug 16, 2021
- Contract value 100% obligated
- $227,812.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Reston, VA 20190, USA
- Legislative mandates
-
- Walsh-Healey Public Contracts Act FAR subpart 22.6
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $133,661 | |
| Original award | $94,151 |
About this award
This federal contract award, valued at $227,812.77, was issued by the Defense Health Agency to Leidos, Inc. for the Prostate Cancer Research Program. The goal of the program is to improve the quality of life, enhance outcomes, and improve overall health and wellness for service members impacted by prostate cancer. This contract is not set aside for any specific business category.
Leidos, Inc. is a global technology and engineering solutions provider serving the U.S. federal government across multiple sectors, including defense, intelligence, health, and civilian markets. The company provides a comprehensive range of technical, scientific, and administrative services through its Leidos Services Operating Segment, which does business as SAIC. Leidos Holdings, Inc. is the parent company of Leidos, Inc. and has demonstrated extensive capabilities in delivering diverse goods and services to federal agencies, including medical research program support, IT infrastructure modernization, and engineering services for complex government missions.
Quick answers
Who was awarded contract HT942525F0213?
HT942525F0213 was awarded to Leidos, Inc. by Defense Health Agency (Department of Defense) on July 1, 2025.
How much is contract HT942525F0213 worth?
The government has obligated $227,813 on HT942525F0213.
Is contract HT942525F0213 an order under another contract?
Yes. HT942525F0213 is a delivery order under HT942523D0002, an indefinite delivery contract.
Was contract HT942525F0213 competed?
The extent of competition for HT942525F0213 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award